Idiopathic Parkinson's disease patients at the urologic clinic

Neurourology and Urodynamics

Volumn 30, Issue 7, 2011, Pages 1258-1261

  Ragab, Maged M ^a   Mohammed, Ehab S ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

International Prostate Symptom Score; Parkinson's disease; urodynamic

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH CENTER; HUMAN; IDIOPATHIC DISEASE; INTERNATIONAL PROSTATE SYMPTOM SCORE; MALE; NOCTURIA; OVERACTIVE BLADDER; PARKINSON DISEASE; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; URINARY URGENCY; URODYNAMICS; UROLOGIC CLINIC;

AGED; ANALYSIS OF VARIANCE; DISEASE PROGRESSION; EGYPT; FEMALE; HEALTH STATUS INDICATORS; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; NOCTURIA; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PROSTATE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE; URINATION DISORDERS; URODYNAMICS; UROLOGY DEPARTMENT, HOSPITAL;

EID: 80052074518     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20983     Document Type: Article

References (31)

1. Clarke C,. Parkinson's disease in practice, 2nd edition. London: Royal Society of Medicine Press Ltd; 2006.
2. Chaudhuri KR, Healy DG, Schapira AH,. Non-motor symptoms of Parkinson's disease: Diagnosis and management. Lancet Neurol 2006; 5: 235-45. (Pubitemid 43238347)
3. Chaudhuri KR,. The dopaminergic basis of sleep dysfunction and non motor symptoms of Parkinson's disease: Evidence from functional imaging. Exp Neurol 2009; 216: 247-8.
4. Hoehn MM, Yahr MD,. Parkinsonism: Onset, progression and mortality. Neurology 1967; 17: 427-42.
5. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29: 4-20.
6. Defreitas GA, Lemack GE, Zimmern PE, et al. Distinguishing neurogenic from non-neurogenic detrusor overactivity: A urodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson's disease. Urology 2003; 62: 651-5. (Pubitemid 37204998)
7. Pavlakis AJ, Siroky MB, Goldstein I, et al. Neurourologic findings in Parkinson's disease. J Urol 1983; 129: 80-3. (Pubitemid 13148057)
8. Stocchi F, Carbone A, Inghilleri M, et al. Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 1997; 62: 507-11. (Pubitemid 27237061)
9. Porter B, Walker R,. The night time problems facing Parkinson's patients CM. J Geriat Med 2006; 8: 99-103. (Pubitemid 44650822)
10. Sammour ZM, Gomes CM, Barbosa ER, et al. Voiding dysfunction in patients with Parkinson's disease: Impact of neurological impairment and clinical parameters. Neurourol Urodyn 2009; 28: 510-5.
11. Winge K, Skau AM, Stimpel H, et al. Prevalence of bladder dysfunction in Parkinsons disease. Neurourol Urodyn 2006; 25: 116-22.
12. Suchowersky O, Furtado S, Rohs G,. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease. Mov Disord 1995; 10: 337-40.
13. Araki I, Kitahara M, Oida T, et al. Voiding dysfunction and Parkinson's disease: Urodynamic abnormalities and urinary symptoms. J Urol 2000; 164: 1640-3.
14. Blackett H, Walker R, Wood B,. Urinary dysfunction in Parkinson's disease: A review. Parkinsonism Relat Disord 2009; 15: 81-7.
15. Hobson P, Islam W, Roberts S, et al. The risk of bladder and autonomic dysfunction in a community cohort of Parkinson's disease patients and normal controls. Parkinsonism Relat Disord 2003; 10: 67-71. (Pubitemid 37476309)
16. Seki S, Igawa Y, Kaidoh K, et al. Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats. Neurourol Urodyn 2001; 20: 105-13. (Pubitemid 32096332)
17. Andersen JT,. Disturbances of bladder and urethral function in Parkinson's disease. Int Urol Nephrol 1985; 17: 35-41.
18. Aranda B,. Vesical sphincter disorders in Parkinson disease. Rev Neurol (Paris) 1993; 149: 476-80. (Pubitemid 23329293)
19. Aranda B, Cramer P,. Effects of apomorphine and L-dopa on the parkinsonian bladder. Neurourol Urodyn 1993; 12: 203-9. (Pubitemid 23160774)
20. Giannantoni A, Rossi A, Mearini E, et al. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. J Urol 2009; 182: 1453-7.
21. Kabay SC, Kabay S, Yucel M, et al. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease. Neurourol Urodyn 2009; 28: 62-7.
22. Gray R, Stern G, Malone-Lee J,. Lower urinary tract dysfunction in Parkinson's disease: Changes relate to age and not disease. Age Ageing 1995; 499: 504-24.
23. Winge K, Fowler CJ,. Bladder dysfunction in Parkinsonism: Mechanisms, prevalence, symptoms, and management. Mov Disord 2006; 21: 737-45. (Pubitemid 44028290)
24. Araki I, Kuno S,. Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score. J Neurol Neurosurg Psychiatry 2000; 68: 429-33. (Pubitemid 30248741)
25. Resnick NM, Yalla SV,. Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients. JAMA 1987; 257: 3076-81. (Pubitemid 17078919)
26. Singer C,. Urinary dysfunction in Parkinson's disease. Clin Neurosci 1998; 5: 78-86.
27. Chancellor MB, Rivas DA,. American Urological Association symptom index for women with voiding symptoms: Lack of index specificity for benign prostate hyperplasia. J Urol 1993; 15: 8-0: 1706 discussion 8-9.
28. Chancellor MB, Rivas DA, Keeley FX, et al. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction. Br J Urol 1994; 74: 200-3. (Pubitemid 24282767)
29. Lepor H, Machi G,. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology 1993; 42: 36-40; discussion 1.
30. Brusa L, Petta F, Pisani A, et al. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease. Neurology 2007; 68: 1455-9. (Pubitemid 46685914)
31. Winge K, Werdelin LM, Nielsen KK, et al. Effects of dopaminergic treatment on bladder function in Parkinson's disease. Neurourol Urodyn 2004; 23: 689-96. (Pubitemid 39313943)